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ABSTRACT 
Rous Sarcoma Virus (RSV) is a simple retrovirus that relies on host cell 
machinery for gene expression after integration of its reverse transcribed RNA genome. 
Three viral RNAs are transcribed from the proviral genome, one of which is the full-
length, unspliced transcript that serves as the RNA genome for progeny virions as well as 
the mRNA for Gag and Pol proteins. The transcript contains features uncommon in host 
cell mRNAs, including a long 3´ untranslated region (UTR), making it a putative target of 
the nonsense-mediated mRNA decay (NMD) pathway. However, this viral mRNA is 
protected against NMD by a small RNA element known as the RSV RNA stability 
element (RSE). Truncation experiments performed on the RSV RSE to identify its core 
element yielded partial phenotypes, suggesting the presence of redundant sub-elements 
across the region. 
We conducted a random mutagenesis screen to determine the consensus 
sequences crucial for this insulator effect. Polypyrimidine tract-binding protein (PTBP1) 
was identified as a potential candidate that may interact with the RSV RSE to confer 
RNA stability. This protein was also independently identified by our collaborators in an 
in vivo RNA pull-down and mass spectrometry screen. Mutation of PTBP1 binding sites 
in the RSV RSE results in destabilization of the full-length transcript, and this 
destabilization can be rescued by re-introducing exogenous PTBP1 binding sites. 
However, PTBP1 does not fully account for the effects of the RSV RSE. RNA structure, 
as well as other proteins that may cooperatively bind the RSE or to PTBP1, may also be 
important for RNA stability. 
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 As the NMD-prone features of RSV RNA are common to other retroviruses, we 
hypothesize that there may be similar RSE-like RNA elements present in other 
retroviruses as well. Regions of the 3´ UTR in Human Immunodeficiency Virus (HIV) 
and Moloney-Murine Leukemia Virus (MMLV) are capable of stabilizing full-length 
RSV transcripts in chimeric RSV constructs, suggesting that RSE-like elements exist in 
both these retroviruses. We have confirmed the presence of the MMLV RSE upon 
studying it in its natural context. However, it is unclear if HIV does have an RSE, or if it 
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An overview of the retroviral life cycle  
Viruses are obligate parasites with compact genomes that depend on host cells for 
replication. Retroviruses are single-stranded, + strand RNA viruses with a double-
stranded DNA intermediate. Figure 1 [1] depicts an overview of the retroviral life cycle 
[2], using Human Immunodeficiency Virus (HIV), a complex retrovirus, as an example. 
Two copies of its genome, along with viral proteins such as protease, reverse 
transcriptase (RT) and integrase (IN), are packed into the viral capsid and surrounded by 
the envelope. 
Upon infecting a new cell, the surface viral glycoproteins bind receptors on the 
host cell plasma membrane, triggering a membrane fusion event and the release of the 
viral core into the cytoplasm. There, the capsid partially disassembles, allowing dNTPs to 
enter the core. RT uses the viral RNAs as templates to make double stranded DNA, and 
forms a pre-integration complex (PIC) with host and viral proteins. For HIV and RSV [3–
5], this complex gets imported into the nucleus through the nuclear pore, but for Moloney 
Murine Leukemia Virus (MMLV), the PIC stays in the cytoplasm and only enters the 
nucleus when the cell undergoes mitosis. Once in the nucleus, the double stranded 
proviral DNA gets integrated into the host cell genome with the help of IN. 
Thereafter, the provirus essentially hijacks host cell mechanisms to make more 
viruses. The proviral DNA is transcribed by RNA pol II, and the viral RNAs are spliced 
and processed just like other host cell transcripts. Ribosomes translate RNAs to 
synthesize various viral proteins, which are then transported to their appropriate 
locations. Finally, Gag proteins and viral RNA genomes are assembled near the plasma 
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membrane, followed by viral budding, although there is evidence that RSV assembly 
starts in the nucleus [6, 7]. 
For a retrovirus to successfully complete its life cycle, it has to avoid various host 
cell defense mechanisms, such as the RNA surveillance system. This surveillance system 
consists of three major components: non-stop decay [8–10], which detects transcripts 
lacking a stop codon that are translated through the polyA tail; no-go decay [11–13], 
whereby translating ribosomes are unable to read through a strong secondary structure in 
the RNA, causing the ribosome to stall and trigger decay; and nonsense-mediated mRNA 
decay (NMD) [14–16], which presents the biggest threat for retroviruses. 
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Reprinted by permission from Macmillan Publishers Ltd: Stoye, Nature Reviews Microbiology, 2012 
Figure 1: Major events in the retroviral life cycle.	  (a) Viral entry into cells begin with 
the binding to a specific receptor on the cell surface. Membrane fusion occurs either at 
the plasma membrane or from endosomes (not shown). The viral core is released into the 
host cytoplasm, whereby the capsid partially uncoats. dNTPs enter the viral core, 
initiating reverse transcription of the viral genome. The pre-integration complex then 
transits through the cytoplasm, enters the nucleus, and the proviral DNA integrates into 
the cellular DNA. (b) Viral exit begins with proviral DNA transcription by RNA 
polymerase II (RNAPII). The viral RNA is incompletely spliced and exported to the 
cytoplasm, where translation of viral proteins occurs. Gag assembly and viral RNA 
packaging occurs, followed by viral budding through the cell membrane. The virus is 
then release from the cell surface and undergoes maturation by protease. 
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Features of retroviral RNAs predispose them to degradation by NMD 
Retroviruses have compact genomes of less than 10 kilobases (kb), yet code for 8 
or more viral proteins. In contrast, most single cellular genes are much larger than this, 
due to numerous large introns. Retroviruses use a combination of gene expression 
mechanisms, including alternative splicing, frame-shifting and polyprotein cleavage to 
generate multiple gene products from a single primary RNA transcript [17]. The major 
unspliced retroviral mRNAs have features not commonly found in cellular mRNAs, 
including long 3´ untranslated regions (3´ UTRs), retained introns, and upstream open 
reading frames (uORFs). These unusual features predispose the viral RNA towards 
degradation by NMD [18–21]. Nevertheless, the unspliced RNA of RSV, a well-studied 
avian retrovirus, is very stable [22], suggesting the virus has evolved a means to 
overcome degradation by NMD. 
 
An overview of NMD 
NMD was originally proposed to be responsible for degrading aberrant transcripts 
containing premature termination codons (PTCs), thus protecting cells from the 
deleterious effects of C-terminal truncated proteins [23]. Now, however, it also seems to 
provide a mechanism for regulating levels of expression of alternatively spliced 
mRNAs[21], and serves a regulatory role across the transcriptome [24].  
NMD is a translation termination event; decay is inhibited when translation is 
halted. The key component of this pathway is the ATP-dependant RNA helicase Up-
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frameshift 1 protein (Upf1) [25–28]. Smg1, which phosphorylates Upf1, is also required. 
Other factors, such as Upf2 and Upf3 may also be involved in triggering NMD, and 
decay is mediated via Smg5, Smg6, and Smg7, as well as other decay factors such as 
Xrn1 [20, 21]. However, there are several mechanistically distinct branches of NMD, and 
the factors required and involved for the different branches vary [29]. 
 
Are downstream EJCs necessary for NMD? 
Canonical NMD in mammalian cells posits that the process is mediated by the 
interaction between the terminating ribosome at a PTC and a downstream exon-junction 
complex[26] (EJC), the multi-protein complex deposited 20-24 nts upstream of the exon-
exon junction during RNA splicing [30, 31] (see Fig. 2b, compared to 2a). However, 
examples of EJC-independent NMD exist in mammals and are the rule in lower 
organisms such as yeast [32]. Some, but not all, mRNAs bearing features such as uORFs 
and long 3´ UTRs are NMD targets [18–21], both in mammals and in yeast. Unspliced 
(and presumably lacking EJCs) avian retroviral mRNAs are also targets of NMD [33]. 
NMD has been shown to play regulatory roles in humans, Drosophila melanogaster, 
Caenorhabditis elegans, and Saccromyces cerevisiae [21], and can affect more than a 
quarter of all expressed mammalian genes [34, 35]. 
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Metze et al [29] compared “EJC-enhanced” and “EJC-independent” NMD in 
mammalian cells, and showed that they represented two partially redundant degradation 
pathways, each involving different NMD factors. EJC-independent NMD shows a 
stronger dependence on Upf2 and Upf3. NMD targets are degraded either by Smg6 
endonuclease or Smg5/Smg7, which interact with each other and appear to have 
exonuclease activity. However the inhibition of a decay pathway leads to the usage of the 
other pathway. Nonetheless, all PTC-containing mRNAs are degraded in a Smg1- and 
Upf1- dependent manner, regardless of the presence or absence of a downstream EJC. 
The EJC could therefore serve as a non-essential, indirect NMD enhancer by increasing 
translation efficiency, a role that has previously been demonstrated [36], along with its 
role in mRNA export. 
Saulière et al [37] and Singh et al [38] recently monitored EJC binding across the 
transcriptome in HeLa and HEK293 cell lines, respectively. These studies showed that 
canonical EJCs (cEJCs) are only detected at 80% of exon junctions and at varying 
occupancy levels, so that many individual mRNAs lack EJCs at many exon junctions. 
Surprisingly, almost half of all mapped EJC binding sites were found distributed across 
the mRNA coding sequence rather than at the exon junctions [37, 38]. Furthermore, 
Saulière et al observed an enrichment of the serine/arginine-rich (SR) protein consensus 
binding motif GAAGA near the mapped EJC binding sites, and showed that SRSF1 
(ASF/SF2) and SRSF7 (AAG3/9G8) physically associate with EJCs [37]. SR proteins are 
RNA binding proteins that recruit splicing factors. Correspondingly, Singh et al found 
that multiple EJCs were often associated with many SR proteins in large complexes [38]. 
This interaction between EJCs and SR proteins could explain the previously observed 
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promotion of NMD by overexpression of the SR protein SRSF1 [39]. This blurs the 
distinction between the two branches of NMD [29], as transcripts with downstream 
introns may not have EJCs occupying them and transcripts thought to undergo EJC-
independent NMD may in fact possess non-canonical EJCs (ncEJCs). Most transcripts 
carry both cEJCs and ncEJCs [37, 38]. However, EJCs are rarely seen in the UTRs or in 
intronless mRNAs [37, 38]. 
NMD studies have also been done on two togaviruses, the Semliki Forest virus 
(SFV) and Sindbis virus (SINV), which are + strand RNA viruses that replicate in the 
cytoplasm. SFV and SINV viral RNAs are polycistronic RNAs with long 3´ UTRs that 
undergo NMD upon entering the cell [40]. These RNAs do not enter the nucleus and 
presumably do not have EJCs; there is no evidence of EJCs loading onto RNAs in the 
absence of splicing, even though EJC proteins are present in the cytoplasm. This lends 
further support to the hypothesis that EJCs are not required for NMD. 
 
PABP stabilizes RNA 
A different model was put forward to explain how yeast cells discriminate 
between normal and aberrant termination codons. (See Fig. 2c, compared to 2a.) Long 3´ 
UTRs were shown early on to be associated with NMD in yeast, leading to the faux UTR 
model that suggests these UTRs promote NMD because they lack termination regulatory 
factors normally present on legitimate 3´ UTRs [41]. Since cytoplasmic poly(A) binding 
proteins (PABPC1) tethered near a terminating ribosome can prevent NMD [42], it was 
proposed that long 3´ UTRs induce NMD by distancing the PABPs from the terminating 
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ribosome. Studies with recombinant mRNAs in Drosophila also showed the importance 
of a short distance between a termination codon and poly(A) for stable mRNA [43]. 
While Drosophila has EJCs, they do not seem necessary for NMD in flies [43]. An 
artificial mammalian mRNA with a long 3´UTR could be protected from NMD by 
looping the 3´ UTR via base-pairing to bring the poly(A) tail close to the termination 
codon [44]. Similarly, tethering PABP near a PTC also stabilizes the mRNA. [44, 45] 
 
How does UPF1 recognize target RNAs? 
Despite being the key component of the NMD pathway, it is not well understood 
how Upf1 recognizes and binds its targets.  Recent work has attempted to answer that 
question. Hogg and Goff showed that Upf1 directly binds to 3´ UTRs of several mRNAs 
(HIV-1, Smg5 and GAPDH) in a length-dependent, translation-independent manner [46]. 
In contrast, Kurosaki and Maquat observed that Upf1 binding to non-PTC-containing ß-
globin constructs does not correlate with 3´ UTR length [47]. Furthermore, transcripts 
that contain PTCs or downstream EJCs demonstrate augmented Upf1 binding, and this 
enhanced binding depends on translation. They propose that Upf1 is loaded onto the 3´ 
UTRs of PTC-containing mRNAs at the terminating ribosome. [47]  
Two recent studies interrogated Upf1 binding across the transcriptome in murine 
embryonic stem cells (mESCs) and HeLa cells via crosslinking/immunoprecipitation-
sequencing (CLIP-seq) and individual-nucleotide-resolution UV cross-linking and 
immunoprecipitation (iCLIP) [48, 49]. Both studies agree that Upf1 preferentially binds 
the 3´ UTR at up to 10 times higher levels than the coding sequence. The binding is 
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relatively uniform across the 3´ UTR; however, both groups observed clustering in 
specific locations in individual transcripts. In addition, Hurt et al [49] observed a binding 
preference for G-rich sequences and RNA regions with secondary structure, while Zünd 
et al [48] noted enrichment at U-rich sequences. Notably, translation inhibition causes a 
dramatic increase in Upf1 binding to the coding sequence [48, 49]. Upf1 also binds long 
nonconding RNAs (lncRNAs). Thus, in contrast to current models proposing that Upf1 is 
specifically recruited to the 3´ UTR by ribosomes, these studies suggest that Upf1 is 
uniformly bound across transcripts and is displaced by the translocating ribosome. This 
implies that Upf1 binding happens prior to the selection of NMD targets. Accordingly, 
Zünd et al do not observe a preference for Upf1 binding to NMD targets. [48] 
Nonetheless, it is still unclear how 3´ UTR length functions as a determinant of 
NMD susceptibility in this model, and how increased Upf1 binding promotes NMD and 
increases decay efficiency. One possible model is that Upf2 and Upf3 find and bind the 
RNA-bound Upf1 through diffusion. [21] This primes the Upf1-Upf2-Upf3 complex for 
signaling decay upon interaction with the terminating ribosome. Longer 3´UTR’s usually 
bind more Upf1 [50] and have an increased probability of interacting with diffusing Upf2 
and Upf3 factors. 
 
Alternative polyadenylation and other mechanisms to modulate 3´ UTR length 
Cellular mechanisms exist to modulate 3´ UTR length, which may affect mRNA 
localization and translational efficiency in addition to its stability. Deletions within the 3´ 
UTR, as well as point mutations that lead to premature cleavage and polyadenylation, 
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alter 3´ UTR length and sequence. [51, 52] Chromosomal translocations have also been 
shown to result in 3´ UTR swapping between genes. [53] In addition, alternative cleavage 
and polyadenylation (APA) is a recently studied post-transcriptional regulation. [53–55] 
Most genes contain multiple polyadenylation signals, in both the 3´ UTR and the coding 
sequence. Use of an APA signal in the coding sequence will generate different protein 
isoforms, whereas use of an APA signal in the 3´ UTR will yield mRNA isoforms with 
varying 3´ UTR lengths and associated regulatory elements. In humans, APA signals are 
used in half of all genes. [56, 57] 
 
Retroviral mechanisms to avoid NMD 
Unlike mammalian mRNAs, retroviral mRNAs cannot modulate their stability via 
3´ UTR length switching because they must maintain full-length genomic RNA. The full-
length, unspliced transcript serves as the RNA genome for progeny virions as well as the 
mRNA for structural (Gag) and enzymatic (Pol) viral proteins. [17] Consequently, some 
retroviruses have developed protein-based or RNA-based protective mechanisms against 
NMD. 
Human T-lymphotrophic virus type 1 (HTLV-1) Tax protein	  binds Upf1, as well 
as INT6, a subunit of the translation initiation factor eukaryotic initiation factor 3 (eIF3) 
required for efficient NMD, and sequesters them to ensure viral RNA integrity and 
translation. [58] In addition, Rex establishes a general block to NMD to stabilize both 
viral and host cell transcripts. [59] Of the cellular or viral mRNAs described to evade 
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NMD, the most extensively characterized is a cis-acting RNA sequence found in the 
Rous sarcoma virus (RSV), designated the RNA stability element (RSE). [22, 60, 61] 
RSV is a simple avian retrovirus with three viral RNAs [62] generated from the 
primary transcript by alternative splicing. The full-length RSV mRNA contains several 
NMD-triggering features, including upstream ORFs and a long 3´ UTR. However, the 
RNA is stable in chicken cells and has a long half-life of about 20 hours [22], suggesting 
it has evolved a mechanism to avoid degradation by NMD. 
Studies of mouse HSP70 and human histone H4 unspliced mRNAs found that 
they were resistant to NMD [63], leading to the proposal that all unspliced mammalian 
mRNAs are resistant. On the other hand, most S. cerevisiae mRNAs are not spliced, yet 
they are subject to NMD [20]. Additionally, RSV unspliced RNA with frameshift 
mutations or PTCs in the gag gene is rapidly degraded in a Upf1- and translation-
dependent manner, showing that the transcript is recognized as an NMD substrate, albeit 
in chicken cells. [22, 64]  
Neither the EJC model from mammalian cells or the long 3´ UTR model from 
yeast and drosophila seemed adequate to explain the mechanism of NMD of RSV 
mRNA. Since the mRNA is unspliced, it was not thought to have EJCs. In addition, the 
normal gag termination codon is 7 kb away from the poly(A) tail, generating a very long 
3´ UTR but a stable RNA. In contrast, insertion of a PTC 100 nts or more upstream of the 
normal termination codon results in degraded mRNA. [22] Thus, the distance from 
poly(A) did not seem to be a key determinant here.   
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The finding that PTCs within 100 nts of the normal gag termination codon 
showed partial RNA stability [22] suggested that the sequences downstream of the 
termination codon could be significant in creating a proper context for translation 
termination. Deletion experiments led to the identification of a 400 nt cis-acting RNA 
element in RSV located immediately downstream of gag, termed the RSV RNA stability 
element (RSE). [65] The RSE, which contains redundant sub-elements and a minimal 155 
nt core, stabilizes the full-length mRNA and protects it from NMD. [65, 66] Deletion or 
inversion of this sequence destabilizes the RNA; stability can be rescued by expression of 
a trans-dominant Upf1 mutant to inactivate the NMD pathway. [65] Insertion of the RSE 
after a PTC in gag also rescues the RNA from decay. [65] 
Alignment of 20 different avian retrovirus strains shows that the sequence and 
secondary structure of the RSE is well conserved. [67] This suggests that the RSE may be 
an RNA element that certain viruses have evolved to evade host cell RNA surveillance 
and to stabilize their genome. In addition, the mechanism used by the RSE could perhaps 
already subsist as another facet among the repertoire of RNA regulation methods in a 
cell. RNAs with long 3´ UTRs that escape NMD occur naturally in the cell, for instance 
Cript1 and Tram1. [45] It is possible that they may also have stability elements 
downstream of their termination codons. In support of this hypothesis, a recent study 
showed that for a subset of human mRNAs with long 3´ UTRs, there is a cis-acting 
element within 200 nts downstream of the natural termination codon that is important for 




The RSV RSE confers a novel mode of protection from NMD. One of the main 
goals of my project was to determine its exact mechanism of protection. To achieve this 
goal, I adopted a mutagenesis approach to identify the key sequences in the RSE that are 
crucial for its role in conferring RNA stability. From there, I investigated factors that bind 
the RSE and are involved in RSE-mediated RNA stability. Another goal of my project 
was to determine if this mode of protection against NMD is conserved across other 
retroviruses. For this, I investigated the potential of 3´ UTRs of Moloney Murine 
Leukemia Virus (MMLV) and Human Immunodeficiency Virus (HIV-1) in stabilizing 
chimeric RSV. Thereafter, I deleted their putative RSEs in their natural context to see if 










CHARACTERIZING THE ROUS SARCOMA VIRUS  
RNA STABILITY ELEMENT (RSV RSE) 
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Identifying sequences in the RSV RSE that are crucial for protection against NMD 
Figure 3(a) shows the secondary structure of the RSV RSE RNA as predicted by 
selective 2´-hydroxyl acylation analyzed by primer extension (SHAPE) chemistry and 
RNase digestion. [67] Previous work on the RSV RSE has shown that there are redundant 
sub-elements across its 400 nts, especially in the 5´ and 3´ regions. [65] Weil showed that 
the 5´-most 250 nt fragment (nts 2486–2735) and the 3´-most 280 nt fragment (nts 2606–
2885) of the RSE can partially stabilize full-length RSV RNA, although the overlapping 
130 nt region (2606–2735) is necessary but insufficient for any stabilization effects. 
Withers expanded on that work to show that the minimum central region necessary for 
protection against NMD spans 155 nts, and designates the 2578–2732 nt region as the 
minRSE. [66] To identify all of these sub-elements across the RSE and to parse apart 
their individual contributions to full-length RSV RNA stability against NMD, I decided 
to carry out a random mutagenesis screen to introduce point mutations into the element. 
The goal of the screen is to obtain loss-of-function mutants, and I hypothesized that the 
mutations in the mutant library will cluster at regions important for stability. 
The screen was performed with two different constructs. The first construct (see 
Figure 3b) consists of the C-terminal end of the RNA fragment (C-frag), nts 2578–2885, 
which encompasses the entire element except for the ribosomal frameshift pseudoknot. 
Previous truncation data has shown that the pseudoknot plays no role in RSV RNA 
stability [66]; hence I excluded the region from our mutagenesis to leave the 
frameshifting machinery intact while still covering all other redundant regions. The 
second construct used (see Figure 3c) was the 155 nt central core of the RSE, spanning 
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nts 2578–2732 and denoted minRSE, which is the smallest fragment of the RSE that is 
able to recapitulate wildtype (WT) protection effects against NMD when inserted after 
the natural stop codon (NTC). [66] The minRSE minimized redundancy, and sped up my 
search for important consensus sequences and potential interactors with the RSE. Point 
mutations were introduced into the C-fragment RSE and minRSE by mutagenic PCR, and 
the mutated fragments were respectively cloned back into full-length RSV RNA via the 
EagI and SpeI restriction sites previously engineered into the RSV WT E/S 2.0 vector 
(Figure 3b) and the RSV WT E/S vector [66] (Figure 3c). Figure 3b and 3d depict the 







Figure 3(e): Random mutagenesis of RSV RSE to identify consensus sequences and 
screen for interaction partners. Left: RNase protection assays (RPAs) on C-frag RSE 
as marked in Fig 3b. C-frag mutants display a range of stabilization effect, and are 
generally more stable than minRSE mutants as expected. Right: RPAs on minRSE as 
marked in Fig 3d. minRSE mutants have different and multiple point mutations, and 




Figure 3e shows the results of the screen. Steady-state viral RNA abundance 
levels were measured and used as a proxy for RNA stability in RNase protection assays 
(RPAs). As compared to the WT, most C-frag mutants exhibited full or partial 
functionality, which is to be expected since it would be rare to concurrently mutate all 
important regions in a single fragment. However, CM2 does show a decrease in RNA 
stability. Most minRSE mutants exhibit a much more severe phenotype, including 
mutants M1, M2, M3, and M14, which have complete loss of function. 
I then mapped the mutations from LM1 and the minRSE loss-of-function mutants 
back onto the sequence and structure of the minRSE (see Figure 3f). There were regions 
where mutations seemed to cluster, with 3 or more of the 5 mutants carrying mutations in 
that region, as well as a few specific nucleotides that were frequently mutated. I was 
particularly interested in the 5´ and 3´ ends of the minRSE, as the deletion of these 
specific regions caused large destabilization effects as demonstrated in Wither’s 
truncation experiments. [66] 
 
PTBP1 is a candidate protein that may interact with RSV RSE  
Focusing on these clusters, I performed a computational analysis, browsing the 
RNA Binding Protein Database (RBPDB) in search of potential protein interactors that 
may bind the RSE. The RBPDB is a curated database of RNA-protein interactions in 
human, mice, flies, and worms, as reported in primary literature. [69] Using a 6 nt motif 
centered on the each of the mutation clusters, I obtained a list of candidate proteins, 
which are listed in Table 1. This search yielded a surprisingly short list, with very little 
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overlap between the clusters. Polypyrimidine tract binding protein 1 (PTBP1) was the 
most interesting candidate as it bound to 12 of the 14 motifs tested. Other interesting 
candidates include serine/argenine-rich splicing factor 1 (SFRS1), which bound to 5 of 
the 14 motifs tested, as well as human antigen R (ELAV1). ELAV1 bound to 5 of the 14 
motifs tested, and was also previously identified by Withers in an MS2 pulldown/mass 














CUCCCU GCUAAC ACGCAA AAAAAG UUACAG CAUAUA CUUCAC 
PTBP1 CSDE1 PTBP1 PTBP1 PTBP1 PUM1 PTBP1 
ZFP36 SSB TUT1 Ybx1 YBX1 TUT1 SFRS1 
PCBP2 Sxl HNRNPA1 CSDA KHDRBS1 HNRNPA1 SFRS7 
PCBP1 Sf1 SART3 ZFP36 SFRS1 gld-1   
ELAV1 KHSRP ELAV1 SFRS1 HNRNPA1 Jsn1   
HNRNPK MIR1236   IGF2BP1 ELAV1 Puf2   
RBM4 NCL   PCBP1 SLBP Puf3   
U2AF2 asd-2   HNRNPK   Mpt5   
SFRS2 Msl5   HNRNPD   ACO1   
SFRS1     MEX3D   IREB2   
MBNL1     HNRNPA1       
Jsn1     ELAV1       
Puf2     PABPC1       
Puf3     TIA1       
Mpt5     TIAL1       
IREB2     SFRS9       
ACO1     HNRNPR       
      SYNCRIP       
      SLBP       
      SNRPB       
      NCL       
      GRSF1       
      Nab2       
      Puf4       
      Mpt5       
Table 1: Candidate proteins that bind highly mutated RSE regions 
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CCGGGU GGUCUU CUUACC UUACUG UUUGCG GCGCGC CGCUGU 
NCL PTBP1 PTBP1 PTBP1 Jsn1 PTBP1 PTBP1 
gtf3a ELAV1 PCBP1 CSDE1 Puf2 PTBP2 SFRS1 
  TIA1 HNRNPK HNRNPD Puf3   SNRPA 
  TIAL1 HNRNPA1 MEX3D Mpt5     
  Slbp SNRNP70 CPEB1       
    HNRNPD KHSRP       
      FUBP1       
      ELAV3       
      PCBP1       
      PCBP2       
      NCL       
      PUM1       
      IGF2BP1       
Table 1 cont’d: Candidate proteins that bind highly mutated RSE regions. Shaded 
row header shows WT motif tested, with red nucleotides representing presence of 
mutations in that nucleotide position obtained from the mutagenesis screen. Columns are 
arranged in 5´ to 3´ order of mutation clusters. PTBP1 (green boxes) binds 12 of the 14 
motifs tested. Other candidates include SFRS1 (blue boxes) and ELAV1 (orange boxes). 
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Efforts to identify proteins involved in RSV RSE stabilization were also 
concurrently made by our collaborators, Bobby Hogg and his postdoctoral fellow Zhiyun 
Ge, from the National Institute of Health (NIH). They showed that the RSV RSE is active 
in human cells, and can stabilize both viral transcripts and human reporter mRNAs with 
long 3´ UTRs when expressed in cis in heterologous constructs. [70, 71] Hogg and Ge 
used human reporter mRNAs in a PP7-based affinity purification and mass spectrometry 
screen to identify proteins that specifically bound the RSV RSE (see Figure 4). The 
human β-globin reporter mRNAs, containing the β-globin gene, SMG5 unstable long 3´ 
UTR, and the 400 nt RSV RSE versus an antisense RSE negative control, were used to 
pull down RNA-bound proteins. The comprehensive mass spectrometry screen yielded a 
number of proteins that were enriched in one sample over the other. PTBP1, which was 
enriched in the RSV RSE containing sample, was thus independently identified by the 
Hogg lab as a candidate protein that may play a role in the protection of long 3´ UTRs 
against NMD. In the same experiment, Upf1 protein is also underrepresented in the RSV 





Figure 4: Identification of RSE-interacting proteins by tandem mass spectrometry. 
Top: Schematic of β-globin reporter mRNA constructs used for PP7-based affinity 
purification. The RSE sequence (top) and a control sequence, the antisense RSE sequence 
(bottom) were inserted into reporter mRNAs containing the β-globin gene and the SMG5 
3´ UTR. Left: mRNP profiles of transcripts. Proteins were separated by SDS-PAGE and 
visualized by Krypton Infrared Protein Stain (Pierce). Right: Purified mRNPs were 
subjected to trypsin digestion and tandem mass spectrometry. Spectral counts from 
selected proteins enriched in either the RSE-containing sample or the antisense RSE 
sample are shown. Figure obtained from Ge and Hogg. 
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PTBP1 is a well-studied protein (reviewed by Romanelli et al) [72] best known 
for its role as a negative regulator of splicing. As its name suggests, it preferentially binds 
to CU-rich regions. It is thought that PTBP1 binds the polypyrimidine tract of the splice 
acceptor site, thus preventing spliceosome components from binding. In addition, PTBP1 
contains four RNA recognition motifs (RRMs), which can bind different regions of the 
RNA and promote RNA looping, in line with its role as a splicing regulator. An analysis 
of the RSV RSE sequence shows that the element may contain up to eleven putative 
PTBP1 binding sites. 
I verified this binding via an electrophoretic mobility shift assay (EMSA). 
Increasing amounts of PTBP1 protein were added to 40 ng of WT RSV RSE RNA and 
allowed to bind at 30ºC for 15 mins before the samples were run on 4% PAGE for 6 hrs 
at 4ºC. As shown in the top gel of Figure 5bi, PTBP1 binds WT RSE RNA and causes at 
least three discrete band shifts when added in increasing concentrations.	  The first shift 
starts to appear in lane 3, at 0.16:1 molecules of PTBP1 protein:WT RSE RNA. Lane 6, 
with 38.4 nM PTB, is where we see more RNA in the first complex than unbound RNA, 
and also the lane we first see a second 2nd shift. That corresponds to 1.21:1 molecules of 
PTBP1:WT RSE. The third shift is faint but observable in lane 7, and becomes clearer in 
lane 8. These discrete band shifts each indicate a specific complex formed by PTBP1 
binding to the WT RSV RSE RNA. The binding did not result in large mobility shifts, 
which may mean that the RNA remained folded in the complex. 
In lane 9, we can observe unbound WT RNA, the three different specific RSE-
PTBP1 complexes, as well as a smear. One possible explanation of the smearing is 
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simply due to a supershift from additional proteins bound per RNA. The exact dynamics 
of PTBP1 binding to RNA are not well understood. Current understanding in the field 
suggests that stable PTBP1-RNA binding only requires 1 to 2 RRMs per PTBP1 
molecule to be bound to a high-affinity binding site; a CU-dinucleotide will suffice for 
each of its other RRMs to bind. In addition, RRMs 3 and 4 can interact and bind to each 
other, both within the same molecule and across mutiple molecules to cause 
multimerization of the protein. Thus, at high protein concentrations when PTBP1 is 
present in excess of its binding substrates, smearing such as that observed in lane 9 may 
happen. In vast excess amounts of PTBP1, the protein and RNA aggregate, yielding a 
distinct band such as those observed in lanes 10–14 of the gels in Figure 5b. 
However, a more likely explanation includes the unfolding of the RSE structure. 
As a negative control, I performed an EMSA using the 400 nt RSV antisense RSE RNA 
as a binding substrate for PTBP1 (Figure 5bi, bottom gel). Compared to the wildtype, I 
do not observe ribonucleoprotein (RNP) complex formations when the corresponding 
amounts of protein and AS-RSE RNA were used. Instead, smears were observed. This 
demonstrates the degree of non-specific RNA binding by PTBP1. Note that the smearing 
occurs in nearly the same concentration range as the specific complex formations in the 
WT RSE gel, but the change in mobility is large. This likely indicates a different type of 













PTBP1 is important for RSE-mediated RNA stability 
To test the role of PTBP1 in stabilizing long 3´ UTRs, Hogg and Ge generated a 
∆PTB mutant, in which they mutated all putative PTBP1 binding sites in RSV RSE by 
mutating CU dinucleotides to AGs (see Figure 5aii versus 5ai). Two additional RSV RSE 
variants were also generated, in which three and six exogenous PTBP1 binding sites that 
had been previously validated were added back to the ∆PTB mutant (Figure 5aiii and 
5aiv respectively). This allows us to rescue any potential phenotype the ∆PTB mutant 
may exhibit.  
EMSAs were performed to evaluate PTBP1 protein binding to these RSV RSE 
variant RNAs (see Figure 5bii). With RSE∆PTB, I observed smeared bands in the same 
concentration range as the non-specific binding to AS-RSE in Figure 5bi. This smearing 
was partially rescued by the addition of 6 PTBP1 binding sites in the RSE∆PTB+6xPTB 
variant. This suggests that WT RSE RNA forms specific, structured complexes with 
PTBP1 whereas the AS-RSE, RSE∆PTB, and to a lesser extent the RSE∆PTB+6xPTB, 
binds PTBP1 non-specifically. The difference in binding affinity does not appear to be 
large; the main differences between the WT RSE and the RSE variants appear to lie in the 
structural homogeneity and compactness of the specific versus non-specific complexes. 
In addition, I performed gel shift competitions, using cold RSE variant RNAs as 
competitors for radiolabeled WT RSE RNA (see Figure 5c). 40 ng of hot WT RSE RNA 
were used to bind PTBP1 at concentrations ranging from 7.68 nM to 76.8 nM, 
corresponding to lanes 4–8 of the EMSAs in Fig 5b. Cold RSE variant RNAs were then 
added in different ratios. Cold RSE∆PTB RNA was not an efficient competitor for hot 
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WT RSE RNA, showing that it does not bind PTBP1 as well as WT RSE RNA. On the 
other hand, cold RSE∆PTB+6xPTB RNA was able to compete with WT RSE RNA and 
prevent RNP complex formation, showing that the RNA is able to bind PTBP1.  
I cloned the RSV RSE variants back into the full-length virus and performed 
RPAs to evaluate the effects of PTBP1 binding on full-length viral RNA abundance (see 
Figure 5c). ∆PTB shows a very striking decrease in abundance levels of RSV RNA; this 
mutant is present in even lower levels than deleting the entire 400 nt RSE. The addition 
of three and six PTBP1 binding sites back to the ∆PTB mutant does rescue RNA levels in 
a dose-dependent fashion. Furthermore, co-transfection of dominant-negative (DN) Upf1 
restores RNA levels in the addback mutants back to WT levels (see Figure 5d). This tells 
us that these RSE sequences, which are putative PTBP1 binding sites, are important for 
protecting full-length RSV RNA against NMD. 
 
PTBP1 binds RSV RSE to prevent Upf1 binding 
Hogg and Ge also quantitated PTBP1 versus Upf1 protein binding to these RSE 
variants. Using PTBP1 and Upf1 in a co-immunoprecipitation experiment, they pulled 
down human reporter mRNAs from cell lysates and performed northern blots to detect 
the levels of the respective RSE-variant-containing RNAs recovered. The results are 
shown in Figure 6, where we can observe an anti-correlative trend. Comparing the ∆PTB 
to the 6xPTB, it is clear that when there is more PTBP1 binding, we correspondingly see 
less Upf1 binding. 
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From these data, we developed a model of the mechanism of RSV RSE protection 
against NMD (refer to Figure 7). The RSV RSE binds PTBP1, which competitively 
inhibits Upf1 from binding downstream of the gag stop codon. As such, even though the 
RNA still has a long 3´ UTR when the ribosome terminates, the ribosome is unable to 
sense the actual 3´ UTR length since there is no downstream Upf1 molecules to interact 




PTBP1 binding sites are enriched downstream of the gag stop codon in RSV genome 
Why does the ∆PTB mutant show a more severe phenotype than deleting the 
entire RSE? To answer this question, I looked at PTB binding site distribution across the 
entire RSV genome. Hogg and Ge had previously analyzed and identified a list of 
pentamer and hexamer sequences that were enriched in publicly available PTB CLIP-seq 
data sets, which signify high-affinity PTBP1 binding (see Table 2). Using a python script 
written by Nathan Lee, an undergraduate research assistant in the Beemon lab, I scanned 
the RSV genome for these high-affinity binding sites and plotted their frequency in 50 nt 





































PTBP1 binding sites are most enriched in the region downstream of the gag stop 
codon, including the RSE (green box in Figure 8a). The 5´ end of the box shows a region 
devoid of PTBP1 binding sites; this region corresponds to the ribosomal frameshifting 
pseudoknot, and corroborates our previous finding that deletion of the pseudoknot does 
not affect RNA stability. In addition, there are a number of PTBP1 binding sites 
immediately downstream of the box, which explains why ∆PTB has a more severe effect 
than ∆RSE: When the entire RSE is deleted, I am essentially shifting those downstream 
PTBP1 binding sites closer to the RSV gag stop codon, hence yielding a partial 
phenotype. In contrast, only the PTBP1 binding sites are mutated in the ∆PTB mutant. 
This creates a zone of PTBP1 exclusion, in turn allowing Upf1 to bind and trigger NMD 
of the RNA. In hindsight, the 400 nt region of the RSV 3´ UTR designated as the RSV 
RSE is an arbitrary attribution. In light of this PTBP1 binding site distribution data, we 
should adjust the designation of the RSV RSE to reflect the region encompassing the 
maximum number of PTBP1 binding sites, as shown by the box in Figure 8b, which 
spans nts 2650-3050. 
 
Structural analysis of the RSV RSE RNA 
A closer analysis of Figure 6 indicates that we still do not fully understand how 
the RSV RSE functions. Even though the 6xPTB RSE variant binds PTBP1 better than 
WT RSE, the WT RSE is still superior in inhibiting Upf1 binding. There are a few 
possible explanations for this, including RNA structure or cooperative binding with other 
proteins. 
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RNA structure may directly affect RNA stability by way of affecting PTBP1 
positioning with regards to the stop codon. For instance, the 5´ end of the minRSE and C-
frag is a CU-rich region that is 92 nts away from the gag stop codon. However, due to the 
secondary structure of the RNA and the folding of the ribosomal frameshifting 
pseudoknot, that region actually sits directly next to the stop codon at the base of the 
stemloop, and may play a bigger role in RNA stability than otherwise suggested. 
Likewise, the rest of the WT RSV RSE may fold in a way that could either maximize 
PTBP1 binding, or adopt a conformation that would best occlude Upf1 from the region 
and from the terminating ribosome. 
In support of this hypothesis, we performed Mfold on the RSV RSE variant RNAs 
(see Figure 9). The Mfold software predicts optimal and suboptimal 2º structures for 
RNA and DNA molecules based on minimum free energy. [73] The predicted 2º 
structures of all 3 RSE variants are severely disrupted and differ significantly from the 
WT RSV RSE structure. Whereas the WT RSV RSE has 3 distinct domains, consisting of 
the 5´ frameshift pseudoknot, a 3´ GC-rich stemloop, and a flexible central region, the 
RSE∆PTB and RSE∆PTB+3xPTB both form a large, single stemloop, while the 





Figure 9: Mfold of WT RSV RSE variant RNA. Above: WT RSV RSE RNA. On next 
page: RSE∆PTB and RSE∆PTB+3xPTB. On page 48: RSR∆PTB+6xPTB. Nucleotides 
in blue represent the mutations made to generate the EagI site in the E/S vector. 
Nucleotides in red correspond to C to A and U to G mutations made to knock out putative 
PTBP1 binding sites. Nucleotides in magenta represent exogenous PTBP1 binding sites 
added back to the RSE∆PTB construct. 
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Figure 9: Mfold of RSV RSE variants. Left: RSE∆PTB. Right: RSE∆PTB+3xPTB 
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To pursue this further, we initiated two collaborations with structural RNA labs. 
The first collaboration is with Yuan Yuan Liu from the Michael Summers Lab at 
University of Maryland – Baltimore County. The Summers Lab is renowned for pushing 
the boundaries of RNA size limitations for 2-dimensional nuclear magnetic resonance 
(2D-NMR). For this collaboration, I visited the Summers Lab and carried out large-scale 
synthesis and purification of RNAs (see Figure 10a). WT RSV RSE RNA appears to be 
well behaved; both the minRSE RNA and the C-frag RNA run as a single species on a 
native gel in H2O and in isoelectric PI buffer (refer to Figure 10b). Additionally, a 
diagnostic 1D-NMR performed on the minRSE RNA shows that the RNA yields the 
same spectra, with or without salt, with sharp and distinct peaks that can be resolved and 
assigned, making it an ideal candidate for 2D-NMR (see Figure 10c). As such, the 
Summers Lab is proceeding with the 2D-NMR experiment on the minRSE RNA. 2D-
NMR on the C-frag RSE is much more technically challenging due to size limitations, 
but we may still pursue it by performing the NMR on partial fragments. 
The second collaboration we initiated is with Rossitza Irobalieva from the Wah 
Chiu Lab at Baylor College of Medicine to perform cryo-electron microscopy (cryo-EM) 
on the RSE RNA. Figure 10d shows preliminary results obtained on the cryo-EM of the 
minRSE. minRSE RNA appears to adopt four different conformations, suggesting 
structural flexibility within the RNA. As cryo-EM is easier with larger RNAs, the Chiu 
Lab is proceeding with cryo-EM of the C-frag RSE, the full 400 nts of the WT RSV RSE, 











INVESTIGATING PUTATIVE RNA STABILITY ELEMENTS IN 
HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND  
MOLONEY-MURINE LEUKEMIA VIRUS (MMLV) 
60	  
Background 
 Are similar stability elements present in other retroviruses, such as HIV and 
MMLV? As can be seen in Table 3, the features that make RSV prone to degradation by 
NMD are not unique traits, but rather traits that are shared by all retroviruses. These 
viruses have very similar genome sizes and structure, generating polycistronic mRNAs 
that code for multiple genes, including gag, pol and env. Likewise, other viruses that 
contain multiple open reading frames may also induce NMD. 
 For HIV and MMLV, since the translating ribosome terminates at the gag stop 
codon the majority of the time, the long 3´ UTR of the full-length unspliced RNA from 
these viruses should trigger NMD, causing the rapid decay of their RNAs. As viruses are 
unable to modulate their 3´ UTR lengths, it is plausible that these other retroviruses may 




Table 3: MMLV and HIV-1 share features of RSV that make them susceptible to 
NMD. RSV and MMLV are simple retroviruses whereas HIV is a complex retrovirus. 
However, they have similar genome sizes and structures, and their unspliced RNAs have 
long 3´ UTRs that may trigger NMD. 
Feature RSV MMLV HIV-1 
Genome size (kb) 9.3 8.3 9.2 
Genes gag, pol, env, src gag, pol, env gag, pol, env, vif, 
vpr, vpu, nef, tat, rev 
Long 3´UTR yes yes yes 
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400 nts of HIV 3´ UTR immediately downstream of the gag stop codon can stabilize 
full-length RSV RNA in a chimeric construct. 
 Since the tools and protocol for evaluating RNA stability in RSV have already 
been developed and optimized, I first wanted to test the potential of the 3´ UTR 
immediately downstream of the HIV gag stop codon in stabilizing RSV RNA. To do this, 
I generated an HIV-RSV chimeric virus by cloning the 400 nt region of the HIV 3´ UTR 
(nts 2303–2692) into RSV∆RSE (see Figure 11a). Additionally, I generated 15 other 
variants of the HIV putative RSE for testing as chimeric viruses, with the constructs 
carrying various combinations of 5´ and 3´ truncations. This was done in light of 
Wither’s truncation studies of the RSV RSE that alluded to functional redundancy across 
the element; I wanted to see if the HIV putative RSE consists of redundant sub-elements 
across the 400 nt region as well. 
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All sixteen variants of the HIV putative RSE were cloned into RSV∆RSE, and the 
stability of full-length RSV RNAs were evaluated by RPA. The results are shown in 
Figure 11b. WT HIV putative RSE appears to be able to stabilize full-length RSV RNA 
as a chimeric virus; in fact, the 400 nt HIV fragment appears to be able to stabilize the 
RSV RNA even better than the original WT RSV RSE. Similarly, the majority of the 
partial fragments of HIV putative RSE appear to confer partial to full functionality to 
RSV RNA in evading NMD; the protection against NMD is only lost with fragments that 
have been severely truncated and only comprise of 100-150 nts. This suggests that HIV 
may indeed have an RSE that is responsible for protecting its long 3´ UTR from being 
degraded by NMD. Previous work done in the lab also suggests that HIV putative RSE in 
the reverse orientation can protect long 3´ UTRs from NMD. [74] As such, I decided to 
move ahead with studying HIV in its natural context, by looking at full-length HIV RNA 
stability upon deletion of its putative RSE, as well as the effects of PTCs inserted into 
HIV gag. 
 With HIV, I left the first 6 nts after the gag stop codon intact as there were 
concerns that those nucleotides may be important for translation termination, and deleted 
the following 393 nts. I then tested HIV full-length RNA stability via RPAs. 
 
65	  
HIV RNA expression level is extremely low in cells 
 I have had very limited success in assessing HIV RNA stability in cells due to its 
low expression levels. My initial hypothesis was that I was not getting efficient 
transfections of my plasmids into cells. In data not shown, I attempted to optimize 
transfections and RPAs of my HIV constructs into a number of different cell types 
(Jurkats, HeLas, HEK293s) using a variety of transfection methods (DEAE-Dextran, 
Lipofectamine 2000, Fugene 6, Fugene HD, electroporation) with varying 
DNA:transfection reagent ratios, but to little success. HeLas and HEK293s seem more 
amenable to transfections than Jurkats, and DEAE-Dextran yielded better results than the 
other transfection reagents and methods. 
 To rule out the possibility of inefficient transfection, I replaced the HIV control 
plasmid with human Globin and its corresponding Globin RPA probe that had previously 
been established in the lab. Figure 12a shows a sample RPA gel of this experiment. 
While Globin yields a very robust band, the HIV band is not present. This rules out 
transfection efficiency being the problem. At the same time, it is highly unlikely that the 
problem lies with the HIV RPA probe; excess undigested HIV probe is detectable, and 
since the probe hybridizes to its targets by simple base pairing, there should be no 
problems with hybridization kinetics. The only next logical conclusion is low expression. 
 Figure 12b shows a titration experiment, whereby I increased the amount of HIV 
DNA transfected up to 10 times higher than what is normally used, as well as increased 
the amount of transfection reagent used to see if I can increase transfection efficiency 
without compromising cell fitness. Increasing the amount of DNA transfected does 
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indeed increase RNA expression levels, and the extra DNA used did not seem to 
negatively affect the cells. Increasing the amount of DEAE-Dextran used, on the other 
hand, did yield stronger RPA bands, but the cells also looked progressively unhealthier 
with more DEAE-Dextran used. As such, I decided to continue my HIV experiments 
using 15µg each of the WT and the control HIV plasmids per 6 cm sample plate, and 
10mg/mL DEAE-Dextran as normal. 
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HIV full-length RNA stability is not affected by the loss of its putative RSE or by 
PTCs inserted into gag. 
 Figure 13 shows the results of RPAs performed on HIV∆RSE in HeLa cells, 
along with a representative picture of an RPA gel. Steady-state abundance levels of HIV 
RNA with its putative RSE deleted is comparable to WT levels, showing that HIV may 
not have an RSE, or that it may not require the RSE for stability and protection against 
NMD. RNA levels did not appear to increase in the presence of DN-Upf1, thus showing 
that WT HIV full-length RNA itself is probably not a natural substrate of NMD that is 
already being rapidly degraded under steady-state conditions.  
 PTCs inserted into HIV gag were previously generated and tested by Weil, who 
observed that the PTCs do not affect the levels of unspliced HIV RNA in the cell. [74] 
There are, however, several caveats to this observation. Firstly, from the gel shown in 
Weil’s thesis, it appears that he faced the same issue of low expression as I did: his HIV 
RPA bands were barely above background and I have hesitations as to how well they 
could be quantified. Secondly, the experiment was only performed once. It would be 
prudent to repeat the experiment a couple more times to ensure that the results can be 
replicated. Lastly, Weil did not delete the nucleocapsid from HIV to prevent RNA 
packaging. Instead, he merely harvested RNAs at an earlier timepoint (24 hrs post-
transfection) in an attempt to examine the RNAs before they had a chance to be 
packaged. However, this means that the plasmids may only have had a short window to 
enter the nucleus and make RNAs. Furthermore, a portion of this already-limited RNA 
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pool may still have been successfully packaged into virions. This may result in the 




 In light of these data, it appears that HIV does not require an RSE to protect its 
full-length RNA from degradation by NMD. There are a few possible explanations for 
our observations. 
  Firstly, the triggering of NMD is a translation-termination event; without 
translation, there will be no decay. To our knowledge, there has not been any studies 
done on how much HIV RNA is being translated. The ribosome footprinting experiment 
done in our lab has also been inconclusive. It therefore stands to reason that perhaps we 
do not see decay because the RNA is being translated at such a low frequency, and that 
NMD-mediated decay of the RNA happens at such a low rate, that RSE-mediated RNA 
stability is indistinguishable from WT stability levels. 
 Another possibility is that the HIV RNA has evolved another mode of protection 
against NMD that is distinct from RSE-mediated RNA stability, making the RNA 
completely immune to NMD regardless of the presence of PTCs and the absence of an 
RSE. If such a mechanism did exist, I would speculate that it evolved after the evolution 
of the RSE, since the HIV RSE does indeed have the capabilities of suppressing NMD of 
PTCs and long 3´ UTRs. 
 One last possibility, albeit quite unlikely, is that the HIV RNA itself does not bind 
Upf1, without which there will be no triggering of NMD. Even though the mechanism of 
how Upf1 is loaded onto RNAs is not well understood, Upf1 is a helicase that binds in a 
sequence-independent fashion and has been found to coat RNAs across the transcriptome. 
Therefore, it is hard to fathom that a specific RNA is able to prevent Upf1 binding 
72	  
completely. Ajamian et al have shown that Upf1 is part of the HIV-1 RNP complex [75], 
although direct binding was not demonstrated. They also showed that Upf1 increases 
HIV-1 expression and translation independently from its role in NMD. The possibility 
exists that this increased expression may be an indirect consequence of NMD inhibition, 
such as in the case of HTLV-1 proteins inhibiting NMD to increase viral expression. [58, 
59] However, global NMD is active in HIV-1 expressing cells, [75] so any increases in 
HIV expression due to NMD inhibition would likely be specific to the viral transcript. 
 Regardless, to continue studying HIV RNA stability, it is important that we 
overcome the technical challenge of low RNA expression levels, so that we are able to 
concretely observe and quantitate mutant phenotypes, if any. One possibility is to use 
qRT-PCRs in lieu of RPAs, as they are much more sensitive to small quantities of 
starting material. Alternatively, we can add a strong promoter in the constructs to 
promote higher rates of transcription.  
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400 nts of MMLV 3´ UTR immediately downstream of the gag stop codon can 
stabilize full-length RSV RNA in a chimeric construct. 
Similar to our studies with HIV, we wanted to explore the presence of an MMLV 
putative RSE, by first testing the potential of the 3´ UTR immediately downstream of its 
gag stop codon in stabilizing full-length RSV RNA as a chimeric virus. This work had 
already been completed by Weil prior to me joining the lab, although the results were not 
reported. As shown in Figure 14, Weil inserted the 400 nt MMLV putative RSE in both 
the forward and reverse orientation behind a PTC in RSV gag and assessed steady-state 
full-length RSV RNA abundance via RPAs. MMLV putative RSE, when inserted in the 
forward orientation behind a PTC, is able to partially stabilize full-length RSV RNA, 
bringing the RNA abundance levels from approximately 25% for the PTC back up to 
70%. When inserted in the reverse orientation however, the antisense MMLV putative 
RSE is no longer able to confer protection against NMD. This suggests that MMLV may 
indeed have a putative RSE that works in a similar fashion to the WT RSV RSE, and I 
decided to proceed with investigating the MMLV putative RSE in its natural context. 
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MMLV RNAs that contain PTCs or lack its putative RSE are destabilized. 
I generated a PTC in MMLV gag by mutating the C at nucleotide position 1326 to 
a T, thus creating an amber stop codon. This should place the PTC 645 nts upstream of 
the natural gag stop codon found at nts 1971–1973. However, since the downstream 
nucleocapsid zinc finger binding domain was deleted, the PTC is actually only 561 nts 
upstream of the gag stop codon. If the MMLV putative RSE is able to protect PTCs 
within 200 nts upstream of the gag stop codon as the RSV RSE does, the C1326T PTC 
should be located outside the range of protection, and the PTC-containing RNA should be 
significantly destabilized. 
Figure 15a shows the RPA results of PTC-containing MMLV RNAs versus WT. 
Although the destabilization effect is not as dramatic as PTCs in RSV, PTC-containing 
MMLV RNAs do reproducibly show a statistically significant decrease in stability, with 
the RNA abundance at 79.7% that of WT levels. This suggests that MMLV full-length 
RNAs can be susceptible to degradation by NMD.  
When the 400 nt putative RSE is deleted, the RNA destabilization phenotype is 
more severe, with the MMLV∆RSE steady-state RNA abundance levels falling to 60% of 
WT levels (see Figure 15b). This is in the range of what I commonly observe for 
RSV∆RSE and suggests that MMLV does indeed possess an RSE that, like the RSV 
RSE, is capable of protecting its long 3´ UTR from degradation by NMD. 
However, attempts to confirm that NMD was responsible for the destabilization of 
MMLV RNAs containing PTCs or lacking the putative RSE have been inconclusive; co-
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transfection with dominant negative Upf1 rescued the decay phenotype in 1 out of 3 trials 




 One explanation for why the PTC-containing MMLV RNA I tested was not 
degraded to a larger extent could be that the MMLV RSE is capable of providing a larger 
umbrella of protection as compared to the RSV RSE. Perhaps the MMLV RSE is simply 
capable of binding a larger number of proteins to prevent Upf1 binding over a larger 
region. Alternatively, the MMLV RSE may promote higher order protein complex 
formations that spread across large regions of the RNA. As such, PTCs at distances that 
are unprotected by the RSV RSE may still be fully or partially affected by the MMLV 
RSE. 
In light of the discovery that PTBP1 binds RSV RSE and is important for the 
RSE’s function in conferring protection against NMD, I wanted to see if PTBP1 might 
also be playing similar roles for HIV and MMLV. In Figure 16, I analyzed the binding 
site distribution across the HIV and MMLV genomes by adapting the python script that 
Nathan Lee previously wrote for analyzing the RSV genome. The green boxes outline the 
putative RSEs in the respective genomes, and it is clear that PTBP1 binding sites are not 




Figure 16: PTBP1 binding sites are not enriched downstream of the gag termination 
codon in both MMLV and HIV. Green boxes mark the respective putative RSE regions. 
(a) PTBP1 binding sites are evenly spread across MMLV genome. (b) PTBP1 binding 











Developing a high-throughput assay to measure steady state RNA abundance levels 
For our purposes, the RPA is a very robust and suitable technique for concurrently 
looking at steady-state RNA abundance levels across a limited number of samples. 
However, it is a long and labor-intensive protocol. As part of my project, I was interested 
in developing another assay that would allow me to screen mutants in a much more high-
throughput fashion. For this, I turned to Spinach (see Figure 17). 
Spinach is an RNA mimic of GFP, comprising of the Spinach RNA aptamer as 
part of a tRNA scaffold, and DFHBI, a drug that specifically binds the aptamer.[76] 
When DFHBI binds the 98 nt aptamer to form the Spinach complex, it fluoresces with 
excitation and emission wavelengths comparable to GFP, thus the output is detectable on 
microscopes and other platforms designed to measure GFP fluorescence. Additionally, 
DFHBI is non-toxic to cells and does not cause autofluorescence when unbound. This 
makes Spinach an ideal system for many live-cell applications, such as visualizing real-
time RNA localization. Different combinations of RNA aptamers and drugs can yield a 
spectrum of fluorescence (Figure 17, right panel) that would enable tracking of multiple 




For my project, I was interested in using Spinach to directly assess transcript-
specific steady-state RNA abundance levels in cells. The goal was to be able to grow and 
transfect cells in 96-well plates, and to measure RNA levels simply by measuring 
Spinach fluorescence via a qPCR machine. This would yield multiple benefits. Firstly, it 
will bring the actual assay time from 4 days for an RPA down to 30 minutes for a scan on 
the qPCR machine. In addition, I would be able to measure a much larger number of 
samples per round of experiment. It is also safer since we would bypass the process of 
generating, testing, and working with radioactive RNA probes. Lastly, it is more cost-
effective, since the qPCR scan is much more sensitive than an RPA and we would be able 
to decrease the scale of our cell cultures, as well as save on the plethora of reagents 
needed to carry out the RPA. 
I decided to tag my RSV RNAs with different numbers of Spinach concatamers 
and empirically decide the ideal number of concatamers to use. In the meantime, I 
transfected cells with the original expression vector obtained from the Jaffrey Lab. 
However, I only observed very faint fluorescence in a small number of cells under the 
microscope. Detection on the qPCR machine also yielded readings that were barely 
above background, and certainly insufficient to use as a reliable measure. Upon 
consultation with other labs trying to utilize Spinach during a conference, I found they 
were having similar issues. Spinach aptamers seem to only fold correctly 20% of the 
time, and the only labs that had marginal success in using Spinach had inserted over 20 
contatamers into their transcript. 
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With that information at that time, I decided that it was no longer worthwhile to 
pursue Spinach for the time being and refocused on the RPA since it already works well. 
Nonetheless, I believe that Spinach is still a valuable tool that should be revisited and 
utilized in future if possible, especially now that the Jaffrey Lab has come up with 
updated versions of Spinach. These include the Spinach2, which folds better compared to 
its previous iteration[77], as well as Broccoli, another RNA mimic of GFP obtained by 
directed evolution via SELEX (Systematic Evolution of Ligands by Exponential 












Figure 18 shows our working model for general retroviral RSE-mediated RNA 
stability, in which long 3´ UTRs are prevented from triggering NMD by the occlusion of 
Upf1 molecules binding near the natural gag stop codon. For RSV, the protein in question 
binding the RSE is PTBP1; however, it is probably not the protein binding the MMLV 
RSE, or the HIV RSE if it exists. There is no reason to suspect that the same protein has 
to be involved across all retroviruses either; any competing factors that can bind the 
region to occlude Upf1 binding would be able to fulfill the same role. 
It seems reasonable to suspect that this is how PABP stabilizes mRNAs without 
long 3´ UTRs: PABP occludes Upf1 from binding near natural termination codons, thus 
providing contextual clues to prevent decay of normal transcripts while still allowing 
PTCs to get detected and degraded via NMD. This explains why RNA stabilization is 
achieved in PTCs and in RNAs with long 3´ UTRs when PABP is artificially brought 
closer to the termination codon in question.  
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Another piece of evidence in support of this hypothesis, albeit weaker, is that 
heterogeneous nuclear ribonucleoprotein L (hnRNPL) appears to be able to succeed 
PTBP1’s capacity in RSE-mediated RNA stability. In data not shown, a previous iteration 
of RSV∆PTB mutant that we previously generated exhibited WT RNA stability. The 
mutant was created by mutating Us to As; in doing so, we inadvertently created CA-rich 
sequences, which are hnRNPL binding sites. Confounding this analysis, however, is that 
hnRNPL has previously been shown to contribute to RNA stability, and it can also 
interact with PTBP1. As such, it is unclear whether the RNA stabilization effects seen in 
the RSE∆PTB+hnRNPL mutant was a result of RSE conferring RNA stability, 
hnRNPL’s inherent capabilities in stabilizing RNAs, or if hnRNPL is recruiting PTBP1 
to the site. 
Nonetheless, the 3´ UTR region in the retroviruses studied for this project each 
code for different proteins (reverse transcriptase for RSV, and different regions of 
protease for HIV and MMLV). Thus, they have different nucleotide sequences and RNA 
2º structures, so we would expect their respective RSEs to bind different proteins. As in 
the discussion in Chapter 3, there is no reason to suspect that only one protein is involved 
in each of these RSEs. For instance, with regards to the RSV RSE, PTBP1 could be 
working in concert with serine/arginine-rich splicing factors, which were also candidate 
protein interactors in my mutagenesis screen and our collaborators’ mass spectrometry 
screen, to coat the RNA near the termination codon. Alternatively, the RSE could recruit 
factors to increase translation termination efficiency and speed up ribosome disassembly 
to prevent decay complex formation. Thus, the sequence immediately downstream of the 
correct viral termination codon, and its associated ribonucleoproteins, is important in 
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validating that termination codon and preventing NMD. Different protein interactions and 
complex formations may affect the range of protection against NMD that each RSE can 
provide.  
 Furthermore, as mentioned in Chapter 1, the 400 nt region is an arbitrary 
designation assigned when the RSE project was first started, based on restriction sites 
[61]. At that time, we only knew that we were looking at an RNA element downstream of 
the RSV gag stop codon that worked in a distance-dependent fashion, with no knowledge 
of its size, structure, or mechanism. 
 Going forward, I think it is important to reconsider our understanding of RSEs 
and refine our approach when studying them. For example, the RSE for a particular 
retrovirus may be bigger or smaller than 400 nts. Instead of looking purely at a particular 
size, we might be better served if we looked for enrichment of protein and protein 
complexes in the regions surrounding the termination codon. Another approach would be 
to consider RNA structure when outlining the region of interest. For instance, according 
to SHAPE data from the Weeks lab [79, 80], the 400 nts currently designated as the HIV 
RSE represents 1.5 stemloops; it may be more appropriate to consider a 500-550 nt 
region so that we are studying two complete stemloops. Our structural RNA collaborators 
are also working on HIV RSE RNA, so future refinements based on their data would also 
be beneficial. 
One other thing to note is that the retroviral mechanism of protecting long 3´ 
UTRs from NMD may be conserved in a subset of human genes. Our collaborators in the 
Hogg Lab performed a global analysis of the role of PTBP1 in regulating RNA stability. 
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As shown in Figure 19a, knocking down PTBP1 in human cells by siRNAs causes a 
decrease in RNA abundance in 535 genes, denoted by the red dots. When a double 
knockdown of PTBP1 and Upf1 was performed, the RNA abundance levels were rescued 
in 188 of these genes, as represented in green. Figure 19b is a continuous distribution 
function plot of 3´UTR lengths. Compared to all genes, these 188 genes on average have 
longer 3´UTRs. Put together, this tell us that these 188 genes have long 3´UTRs that are 
protected against Upf1-mediated NMD by PTBP1, which suggests that they may have 
RSE-like elements that function similar to the RSV RSE. 
In the same vein, a very recent study from the Lykke-Anderson lab has shown 
that for a subset of human mRNAs with long 3´ UTRs, there is a cis-acting element 
within 200 nts of the natural termination codon that is important for RNA stability. [68] 
The 200 nt region tends to be AU-rich for 3´ UTRs that were inhibitory to NMD, 




With increasing gene complexity, organisms have had to evolve mechanisms for 
them to fine tune gene expression, such as increasing 3´ UTR lengths in their RNAs to 
accommodate more regulatory elements. The RSE is thus an ideal tool for these 
organisms to exploit, as it stabilizes natural termination codons in RNAs with long 3´ 
UTRs while still allowing premature termination codons to be degraded. We think it is 
likely that this mode of protection against NMD is conserved in other organisms beyond 
humans and retroviruses. 
We also believe that the RSE has many important potential biotechnical and gene 
therapy applications. The most straightforward application of the RSE would be in RNA 
therapeutics, whereby RNAs are delivered directly to cells in order to generate proteins of 
interest. The RSE can be used to stabilize these RNAs, should they require long 3´ UTRs 
to achieve better regulation. In addition, RSE-mediated RNA stability is an easy post-
transcriptional method to increase protein yield for large-scale manufacturing and 
purification purposes. For gene therapy purposes, being able to deliver multiple genes on 
a single DNA construct is preferable to delivering different genes in trans, as it is more 
costly and technically challenging to achieve efficient transfection rates across a large 
number of cells. The RSE would then be a crucial element to include in the construct 
after each ORF, so that the RNA does not undergo decay. 
As such, the RSE is an important element that should continue to be studied in 
greater detail for us to fully understand the mechanisms of its function. This will 
undoubtedly aid us in our understanding of NMD, and provide a useful biomedical tool in 










MATERIALS AND METHODS 
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Cell cultures and transfections 
Cell cultures and transfections for RSV 
Secondary chicken embryo fibroblasts (CEFs) were grown at 39°C under 5% CO2 in 211 
medium (199 medium supplemented with 2% tryptose phosphate broth, 1% calf serum, 
1% chick serum, and 1% antimicrobial-antimycotic). Transient transfections were 
performed using DEAE-dextran at 100-200 µg/mL (varied based on manufacturer due to 
differential toxicity effects on cells) in serum-free 199 medium as previously 
described.[81] Cells were plated in 6 cm dishes and transfected with 1.5 µg of each 
construct used (3-4.5µg total DNA per plate) at 60% confluency. Total cellular RNA was 
harvested 40-48 hrs post-transfection from CEFs using RNA-Bee (Tel-test) as per 
manufacturer's recommendations. 
Cell cultures and transfections for HIV 
HeLa and HEK293 cells were grown at 37°C under 5% CO2 in DMEM supplemented 
with 10% fetal bovine serum and 1% antimicrobial-antimycotic. Transient transfections 
were performed as described above for CEFs, using 15 µg DNA per 6 cm cell culture 
plate. Transfections using DEAE-dextran were performed in serum-free DMEM. For 
transfections using Lipofectamine 2000, Fugene 6, or Fugene HD, Opti-MEM was used 
for DNA-transfection reagent complex formation, before the complexes were added 
directly to cells in growth medium as per manufacturer's recommendations. 
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Jurkat cells were grown at 37°C under 5% CO2 in RPMI-1640 medium supplemented 
with 10% fetal bovine serum and 1% antimicrobial-antimycotic. Transient transfections 
were performed using Fugene 6 or Fugene HD as described above for HeLas/HEK293s. 
Cell cultures and transfections for MMLV 
NIH3T3 cells were grown at 37°C under 5% CO2 in DMEM supplemented with 10% calf 
serum and 1% antimicrobial-antimycotic. Transient transfections were performed in 
serum-free DMEM as described above for CEFs. 
 
Viral constructs 
RSE mutagenesis screen 
All RSV nts correspond to NCBI reference sequence: NC_001407.1. 
The 10.8 plasmid, ∆RSE plasmid, and 1547C construct previously described[22, 65, 82] 
were used as RSV WT, RSV∆RSE and RSV control plasmids in this study. 
The previously described RSV WT E/S vector[66], which contains an EagI restriction 
site at nt position 2492-2497 and an SpeI restriction site at nt position 2886-2891, was 
used to generate minRSE mutants. 
RSV WT E/S version 2 vector, a variant of the RSV WT E/S vector whereby the EagI 
restriction site was generated at nt position 2572-2577, was previously made by Withers 
(unpublished). This vector was used to generate C-frag mutants. 
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Mutants were generated by mutagenic PCR as previously described[83]. Combine 10 µL 
of 10x mutagenic PCR buffer (70 mM MgC12, 500 mM KC1, 100 mM Tris (pH 8.3 at 
25ºC), 0.1% (wt/vol) gelatin), 10 µL of 10x dNTP mix (2 mM dGTP, 2 mM dATP, 10 
mM dCTP, 10 mM TTP), 30 pmoles of each primer, 20 fmoles of template DNA, and 
bring to 88 µL with dH2O. Mix well. Add 10 µL of 5 mM MnCI2 and mix well. Add 2 
µL (5 U) Taq polymerase for a final volume of 100 µL. Incubate for 30 cycles of 94ºC 
for 1 min, 45ºC for 1 min, and 72ºC for 1 min, without a "hot start" procedure or a 
prolonged extension time at the end of the last cycle. DNA template for the mutagenesis 
was first amplified from the 10.8 RSV viral plasmid and purified from an agarose gel 
using the Fermentas gel extraction kit. Mutagenic PCR primers, designed to include an 
EagI restriction site in the forward primer and an Spel restriction site in the reverse 
primer, were then used to generate amplicons through 3 rounds of mutagenic PCRs. 
Amplicons were cloned into their respective RSV vectors as described below. 
Cloning amplicons into RSV vectors 
Amplicons and WT vectors were digested with EagI and Spel, and the vectors were 
treated with calf intestinal phosphatase. Digested amplicons and vectors were gel-purified 
and ligated before being transformed into E. coli. Clones were screened by colony PCR 
or grown for plasmid purification followed by restriction digests. Selected clones were 
then confirmed by sequencing. 
RSE-PTB variants in RSV constructs 
Plasmids containing RSE∆PTB, RSE∆PTB+3xPTB, and RSE∆PTB+6xPTB were 
obtained from Hogg and Ge. They abolished putative PTBP1 binding sites in the RSV 
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RSE by mutating C to A and U to G to create RSE∆PTB. 3 and 6 previously verified 
exogenous PTPBP1 binding sites were added back to RSE∆PTB to form 
RSE∆PTB+3xPTB and RSE∆PTB+6xPTB respectively. 
RSE variants were amplified from the obtained plasmids by PCR, and the amplicons 
were cloned into RSV WT E/S vector as described above. 
HIV-RSV chimeric virus constructs 
All HIV nts correspond to HIV-1/HTLV-III/LAV reference genome HIV-1 HXB2 strain, 
NCBI reference sequence: GenBank: K03455.1. 
Plasmid pNL43-∆E-GFP was a gift from Robert Siliciano that contains a copy of HIV-1 
proviral DNA on a pUC18 backbone, with EGFP inserted to split and inactivate the viral 
envelope. 
HIV-RSV chimeric virus constructs were generated by amplifying HIV 3´ UTR from 
pNL43-∆E-GFP. PCR primers were designed to include an EagI restriction site in the 
forward primer and an Spel restriction site in the reverse primer. Amplicons were cloned 
into RSV WT E/S vector as described above. 
HIV constructs 
To generate HIV WT vector, I deleted a 105 nt region (nts 1963-2067) in gag containing 
the nucleocapsid (NC) zinc finger binding domains from pNL43-∆E-GFP. 5´ phosphates 
were added to PCR primers using T4 polynucleotide kinase. Primers were purified by 
phenol-chloroform extraction and used for inverse PCR. The PCR product was digested 
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with DpnI and ligated before being transformed into E. coli. Clones were screened by 
colony PCR or grown for plasmid purification followed by restriction digests. Selected 
clones were then confirmed by sequencing. This HIV∆NCCCHC plasmid is used as the 
HIV WT vector for my project. 
A control plasmid was generated by deleting a larger, 147 nt region (nt 1921-2067) from 
pNL43-∆E-GFP gag, also spanning the NC zinc finger binding domains. This was done 
using inverse PCR as described above for HIV WT vector, and the resulting 
HIV∆NCCCHC+ plasmid is used as the HIV control vector for my project. 
MMLV constructs 
All MMLV nts correspond to NCBI reference sequence: NC_001501.1. 
Plasmid pNCS was a gift from Stephen Goff that contains an infectious copy of MMLV 
proviral DNA on a pBR322 backbone modified to include an SV40 origin. I deleted an 
84 nt region (nts 1836-1919) in gag containing the NC zinc finger binding domain from 
pNCS, using inverse PCR as described above for HIV WT vector. This MMLV∆NCCCHC 
plasmid is used as the MMLV WT vector for my project. 
A control plasmid was generated by deleting a 171 nt region (nt 3072-3242) in pol. The 
MMLV WT vector was digested with AvrII. The larger band was gel-purified before 
being transformed into E. coli. Clones were screened by colony PCR or grown for 
plasmid purification followed by restriction digests. Selected clones were then confirmed 
by sequencing. This MMLV∆NCCCHC∆3072-3242pol plasmid is used as the MMLV 
control vector for my project. 
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Upf1 constructs 
WT Upf1 (hUpfl) and dominant negative Upf1 (RR857GA) constructs were gifts from 
Hal Dietz, Johns Hopkins University School of Medicine, and are described previously 
[84]. 
 
RNase protection assays (RPAs) 
RSV RPAs were performed using an RSV gag riboprobe previously described[64] that 
yields a 627 nt band when undigested, 430 nt band for WT RSV, and a 387 nt band for 
RSV control. 
HIV RPAs were performed using an HIV gag probe. The 332 nt probe is complementary 
to nt 1736–2067 of pNL43-∆E-GFP HIV RNA and spans the NC deletion. WT HIV 
yields a 227 nt protected product, and HIV control yields a 185 nt protected product. 
MMLV RPAs were performed using an MMLV pol probe. The 228 nt probe is 
complementary to a 197 nt region spanning nt 2915–3111 of pNCS MMLV RNA. WT 
MMLV yields a 197 nt protected product, and MMLV control yields a 164 nt protected 
product. 
In vitro transcription of antisense viral probes were performed from a T7 DNA template 
and radiolabeled with [α-32P]GTP as previously described[64]. 
Total cellular RNA (10 µg) was resuspended in 30 µL of 80% formamide hybridization 
solution (80% vol/vol deionized formamide, 40 mM piperazine-N,N'-bis(2-
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ethanesulfonic acid) pH 6.7, 1 mM EDTA, 0.4 mM NaCl) containing ~250 000 cpm of 
probe. RNAs were denatured at 95°C and incubated at 42°C for 16 hrs. 300 µL of RNase 
digestion buffer (10 mM Tris-HCl pH 7.5, 300 mM NaCl, 5 mM EDTA, 10 U/mL RNase 
Tl, and 5 µg/mL RNase A) was added and then incubated at 33°C for 45 min. Sodium 
dodecyl sulfate (SDS) and proteinase K were added to final concentrations of 0.6% 
vol/vol and 0.14 mg/mL, respectively, followed by a 20 min incubation at 37°C to stop 
the RNase digestion. The samples were extracted with an equal volume of phenol-
chloroform-isoamyl alcohol (25:24:1) followed by ethanol precipitation. RNAs were 
resuspended in 95% formamide loading dye (95% vol/vol deionized formamide, 0.02% 
bromophenol blue, 0.02% xylene cyanol) and denatured for 3 min at 95°C. Samples were 
electrophoresed on a 6% acrylamide-8M urea sequencing gel. RNA levels were 
quantified using a Typhoon Phosphoimager and GE Imagequant software. 
 
Electrophoretic mobility shift assay (EMSA) 
Sense viral riboprobes were generated via in vitro transcription from a T7 DNA template 
and radiolabeled with [α-32P]GTP as described for RPA probe generation. 
EMSAs were performed as previously described[85]. 1 µL of 38.4 µM PTBP1 protein 
was added to 9 µL autoclaved binding buffer stock (20 mM HEPES pH 7.6, 80 mM 
glutamic acid, 80 mM KOH, 6 mM MgCl2, 20% glycerol) supplemented with 1 mM DTT 
and 0.02% SDS, and incubated at 30ºC for 8 min. 1 µL of 40 ng/µL RSE variant RNA 
was added to the solution and incubated at 30ºC for 15 min. The samples were then 
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incubated on ice for 5 min. 2 µL loading dye (0.25% bromophenol blue, 89 mM Tris pH 
7.6, 89 mM boric acid, 2 mM EDTA, 10% glycerol) was added and the samples were 
electrophoresed on a 4% acrylamide gel (pre-ran for ≥30 mins) for 6 hr at 150V at 4ºC. 
 
Tagging RSV RNAs with Spinach aptamers 
pAV-5S-Spinach plasmid was a gift from Samie Jaffrey, Cornell University. The 171bp 
Spinach aptamer-tRNA scaffold was amplified by PCR using kinased primers, and 
circularized by ligation. Concatamers were generated via rolling circle amplification (GE 
illustra TempliPhi 100 Amplification kit) and re-amplified with primers containing 
restriction sites. Spinach aptamer-tRNA scaffold concatamers were cloned into pol by 
restriction digest and ligation into the RSV WT plasmid. Clones were screened by colony 
PCR or grown for plasmid purification followed by restriction digests. Selected clones 















C-frag mutagenesis F GATTGACCAGCGGCCG 
 
C-frag mutagenesis R CCTGGTTATTCACAGAGACTAGT 
 
minRSE mutagenesis F CGACGGCCGGACCAGTGGCCC 
 
minRSE mutagenesis R CGCACTAGTGGAACAAGCTTGGCGTTA 
 




RSE∆PTB+6xPTB F TAGGGCGGCCGTGATCAAGGTTGCGCTACATTC 
 
RSE∆PTB variants R TGGGGACTAGTGTAAATGCAAAAGCTTCGCGAT
C 
 
RSV RPA gag probe F CGATCGATAGCTAGCATCGACTACGACTGCGCG
GCGTCGGCTCTC 
 
RSV RPA gag probe T7 R TAATACGACTCACTATAGGGTCATCGCTAACGA
GACGGC 
 
EMSA RSE RNA probe T7 F TAATACGACTCACTATAGGGGGAGGGCCACTGT
TCTC 
EMSA RSE RNA probe R GTAAATGCAAAAGCTTCGCG 
 
Spinach-tRNA 5´ stem F GCCCGGATAGCTCAGTCG 
 







2303 EagI F HIV-RSV GACGACCGGCCGGCAACTAAAGGAAGCTCTATTAGA
TACAG 
 
2344 EagI F HIV-RSV GACGACCGGCCGCAGTATTAGAAGAAATGAGTTTGC
CAG 
 
2397 EagI F HIV-RSV GACGACCGGCCGGGAATTGGAGGTTTTATCAAAGTA
AGAC 
 
2441 EagI F HIV-RSV GACGACCGGCCGCATAGAAATCTGTGGACATAAAGC
TATAGG 
 
2539 SpeI R HIV-RSV ATGATGACTAGTGTGCAACCAATCTGAGTCAAC 
 
2592 SpeI R HIV-RSV ATGATGACTAGTCTGGCTTTAATTTTACTGGTACAGT
C 
 
2634 SpeI R HIV-RSV ATGATGACTAGTCTTCTGTCAATGGCCATTGTTTAAC 
 
2692 SpeI R HIV-RSV ATGATGACTAGTGAAATTTTCCCTTCCTTTTCCATCTC 
 
HIV∆NCCCHC/CCHC+ F ACTGAGAGACAGGCTAATTTTTTAGG 
 
HIV∆NCCCHC R CTTAACAGTCTTTCTTTGGTTCCTAAAATTG 
 
HIV∆NCCCHC+ R CATTATGGTAGCTGGATTTGTTACTTG 
 
HIV∆RSE F CAAAAATTGGGCCTGAAAATC 
 
HIV∆RSE R CTATCTTTATTGTGACGAGGG 
 
Sequencing HIV∆RSE CTTCAGAGCAGACCAGAG 
 
HIV RPA gag probe F GGATGACAGAAACCTTGTTGGTC 
 







MMLV∆NCCCHC F GGACCAAGACCCCAGACC 
 
MMLV∆NCCCHC R TTCTCCTCCCTGTCTATCCTG 
 
PTC C1326T F CCAGACTGGGATTACACCACCTAGGCAGGTAG
GAACCACC 
 
PTC C1326T R GGTGGTTCCTACCTGCCTAGGTGGTGTAATCCC
AGTCTGG 
 
MLV∆RSE F TCAAAAGAGCCAGATGTTTCTC 
 
MLV∆RSE R CTAGTCATCTAGGGTCAGGAG 
 
MMLV RPA pol probe F CGATCGATAGCTAGCATCGACTACGACTGCGCA
GTCCCACCCTGTTTGATG 
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